Literature DB >> 15701473

Reliability and validity of the Kansas City cardiomyopathy questionnaire in patients with previous myocardial infarction.

Kjell I Pettersen1, Aasmund Reikvam, Arnfinn Rollag, Knut Stavem.   

Abstract

BACKGROUND: The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a recently developed disease-specific instrument for measuring health-related quality of life (HRQoL) in patients with chronic heart failure (CHF) regardless of aetiology. AIM: To assess the reliability and validity of the KCCQ in patients with previous myocardial infarction (MI). METHODS AND
RESULTS: In 754 myocardial infarction patients who were discharged alive, we collected clinical data from the patients' medical records. Two and a half years after the acute myocardial infarction, we mailed a self-administered questionnaire to the 548 patients still alive. The response rate was 74%. Internal consistency reliability, assessed with Cronbach's alpha, ranged 0.66-0.95. Test-retest reliability, tested with an intraclass correlation coefficient (ICC), ranged 0.41-0.83. The pattern of association between similar and dissimilar scales of the KCCQ and Short Form 36 (SF-36) supported the convergent/divergent validity of the KCCQ. Four of the KCCQ scales and the two summary scores discriminated between patients with and without medication for heart failure, and between different levels of left ventricular ejection fraction (LVEF) supporting different groups validity.
CONCLUSIONS: The Norwegian version of the KCCQ showed acceptable reliability and cross-sectional validity, which support the use of this questionnaire to measure health-related quality of life after myocardial infarction.

Entities:  

Mesh:

Year:  2005        PMID: 15701473     DOI: 10.1016/j.ejheart.2004.05.012

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  18 in total

1.  How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial.

Authors:  Suzanne V Arnold; John A Spertus; Yang Lei; Philip Green; Ajay J Kirtane; Samir Kapadia; Vinod H Thourani; Howard C Herrmann; Nirat Beohar; Alan Zajarias; Michael J Mack; Martin B Leon; David J Cohen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-10

2.  Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.

Authors:  Suzanne V Arnold; John A Spertus; Sreekanth Vemulapalli; Zhuokai Li; Roland A Matsouaka; Suzanne J Baron; Amit N Vora; Michael J Mack; Matthew R Reynolds; John S Rumsfeld; David J Cohen
Journal:  JAMA Cardiol       Date:  2017-04-01       Impact factor: 14.676

3.  Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial.

Authors:  Suzanne V Arnold; Matthew R Reynolds; Yang Lei; Elizabeth A Magnuson; Ajay J Kirtane; Susheel K Kodali; Alan Zajarias; Vinod H Thourani; Philip Green; Josep Rodés-Cabau; Nirat Beohar; Michael J Mack; Martin B Leon; David J Cohen
Journal:  Circulation       Date:  2014-05-23       Impact factor: 29.690

4.  Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke.

Authors:  Raj R Makkar; Sung-Han Yoon; Martin B Leon; Tarun Chakravarty; Michael Rinaldi; Pinak B Shah; Eric R Skipper; Vinod H Thourani; Vasilis Babaliaros; Wen Cheng; Alfredo Trento; Sreekanth Vemulapalli; Samir R Kapadia; Susheel Kodali; Michael J Mack; Gilbert H L Tang; Tsuyoshi Kaneko
Journal:  JAMA       Date:  2019-06-11       Impact factor: 56.272

5.  Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.

Authors:  Suzanne V Arnold; Zhuokai Li; Sreekanth Vemulapalli; Suzanne J Baron; Michael J Mack; Andrzej S Kosinski; Matthew R Reynolds; James B Hermiller; John S Rumsfeld; David J Cohen
Journal:  JAMA Cardiol       Date:  2018-12-01       Impact factor: 14.676

6.  Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry.

Authors:  Suzanne V Arnold; Sean M O'Brien; Sreekanth Vemulapalli; David J Cohen; Amanda Stebbins; J Matthew Brennan; David M Shahian; Fred L Grover; David R Holmes; Vinod H Thourani; Eric D Peterson; Fred H Edwards
Journal:  JACC Cardiovasc Interv       Date:  2018-03-26       Impact factor: 11.195

Review 7.  Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses.

Authors:  Olatz Garin; Montse Ferrer; Angels Pont; Montserrat Rué; Anna Kotzeva; Ingela Wiklund; Eric Van Ganse; Jordi Alonso
Journal:  Qual Life Res       Date:  2008-12-04       Impact factor: 4.147

8.  Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy: Results From the INTERMACS Registry.

Authors:  Suzanne V Arnold; Philip G Jones; Larry A Allen; David J Cohen; Timothy J Fendler; Jonathan E Holtz; Sanjeev Aggarwal; John A Spertus
Journal:  Circ Heart Fail       Date:  2016-08       Impact factor: 8.790

9.  Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry.

Authors:  Suzanne V Arnold; John A Spertus; Sreekanth Vemulapalli; Dadi Dai; Sean M O'Brien; Suzanne J Baron; Ajay J Kirtane; Michael J Mack; Philip Green; Matthew R Reynolds; John S Rumsfeld; David J Cohen
Journal:  Circ Cardiovasc Interv       Date:  2015-12       Impact factor: 6.546

10.  Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure.

Authors:  Nancy Luo; Tiew-Hwa Katherine Teng; Wan Ting Tay; Inder S Anand; William E Kraus; Houng Bang Liew; Lieng Hsi Ling; Christopher M O'Connor; Ileana L Piña; A Mark Richards; Wataru Shimizu; David J Whellan; Jonathan Yap; Carolyn S P Lam; Robert J Mentz
Journal:  Am Heart J       Date:  2017-07-01       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.